AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 262 min read$ORCL

HENLEY JEFFREY sold $63.7M of ORCL

HENLEY JEFFREY (Vice Chairman) sold 400,000 shares of ORACLE CORP (ORCL) at an average of $159.16 ($156.06–$165.57, $63.66M total) across 11 trades on 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · HENLEY JEFFREY
Published Jun 26, 2026, 8:52 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 9:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ORCL
Neutral
medium confidence
Mentioned
$ORCL
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ORCLNeutralLow
01

Why it matters

Traders may monitor whether this is part of a broader insider selling pattern, but the 10b5-1 designation reduces interpretability as a new negative fundamental signal.

02

Market read

A $63.66M insider sale is a concrete datapoint for sentiment, though the pre-arranged nature likely limits immediate price impact absent other catalysts.

03

What to watch

The filing does not state tax, hedging, or compensation context; without additional insider buys/sales or company news, the signal quality is limited.

Relevance 7/10Novelty 5/10Timing: after-hours/filing date (2026-06-26) for an insider sale executed 2026-06-24

Background

The article is an SEC Form 4 insider transaction disclosure for Oracle’s Vice Chairman Henley Jeffrey, executed via an open-market sale under a 10b5-1 plan.

Company-level read

Ticker impact

$ORCLNeutralMedium confidence
Context

Oracle Form 4 shows Vice Chairman Henley Jeffrey sold 400,000 shares in an open-market transaction totaling about $63.66M.

Expected impact

Likely limited/short-lived impact; any effect should be smaller than broader market drivers unless paired with other new disclosures.

Evidence & confidence

The filing is a primary-source Form 4 and the sale size is material, but the article specifies a pre-arranged 10b5-1 plan and provides no accompanying negative company-specific news.

Market effects

Sector

Insider selling in a mega-cap software name can slightly influence sentiment across large-cap enterprise software, but no sector-wide catalyst is disclosed.

Regional

No direct regional market linkage beyond US large-cap sentiment.

Global

No global macro or cross-border transaction details are provided.

Counterpoint

What could challenge this read

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect diversification/liquidity needs rather than a bearish view on Oracle’s prospects.

Key entities

  • Company
    ORCL

    Oracle Corporation; subject of the Form 4 insider sale disclosure.

  • Insider
    Henley Jeffrey

    Vice Chairman; reported open-market sale of 400,000 shares under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 9
$ORCLMedAI 8/10

Oracle Wins $396M Federal HR Cloud Contract

Oracle won a 10-year $395.8M contract from the US Office of Personnel Management to build a governmentwide HR platform on its Fusion Cloud HCM, covering more than two million federal employees. OPM said it will consolidate legacy HR systems into one workflow for personnel actions, payroll and benefits, time and attendance, talent acquisition, and performance management. The award followed court bid protests.

sentinel.ht4 min
AUG 8
$ORCLMed

Oracle Just Won a $7 Billion Pentagon Deal. Can It Fund Its AI Ambitions?

Oracle (ORCL) shares have rebounded after a steep selloff, helped by new AI-related deals. The company won a 10-year Pentagon software contract worth up to $6.99 billion and expanded its Google Cloud partnership to bring Gemini models into Fusion Applications and NetSuite. The article cites $130B debt, rising capex near $56B, negative free cash flow, and a valuation model target price of $226.

tikr.com7 min
AUG 7
$ORCLMed

Oracle price target lowered by UBS amid AI spending concerns

UBS cut its Oracle (ORCL) price target to $245 from $285 but kept a Buy rating, citing risks tied to rising AI infrastructure capex, returns on invested capital, credit-market tightness for AI data center debt, delays at a New Mexico site, and Oracle’s high OpenAI exposure. UBS said some risks are priced in and cited a 90% project Jupiter probability. ORCL was up 1.5% near $145.

proactiveinvestors.com4 min
AUG 6
$ORCLMed

Why Is Oracle Stock Falling Thursday? - Oracle (NYSE:ORCL)

Oracle shares fell on Thursday as investors and credit analysts questioned the financial risks of its debt-funded AI data center expansion. Reuters cited negative fiscal 2026 free cash flow, high capex and about $260B in lease obligations, plus an S&P downgrade to BBB-. Analysts warned leverage could approach 5x EBITDA and risk further downgrades. ORCL premarket was down 3.1% to $139.90. Sept. 8 earnings expected $1.67 EPS on $19.12B revenue.

benzinga.com6 min